Post-Marketing Surveillance of the Safety and Efficacy of Orgalutran (Ganirelix)®

Progevera 10 mg® Versus Orgalutran® in Ovarian Stimulation Cycles of Oocyte Donors

NCT02796105 ·Status: COMPLETED ·Phase: PHASE4

Comparison of the Long GnRH Agonist Protocol and the Flexible GnRH Antagonist Protocol of Ovarian Stimulation

NCT00417183 ·Status: UNKNOWN ·Phase: PHASE4

A Study to Compare the Safety and Efficacy of Cetrotide® 3 Milligram (mg) Versus Antagon™ in Women Undergoing Ovarian Stimulation

NCT00298025 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of BG2109 During Controlled Ovarian Hyperstimulation in Female Subjects Undergoing ART Procedures

NCT05738382 ·Status: UNKNOWN ·Phase: PHASE2

To Investigate Efficacy and Safety of a Single Injection of Org 36286 for Ovarian Stimulation Using Daily Recombinant FSH as Reference (Ensure)(P05690/MK-8962-001)

NCT00702845 ·Status: COMPLETED ·Phase: PHASE3

GnRH Antagonist for Treatment of Early Ovarian Hyperstimulation Syndrome

NCT01268761 ·Status: COMPLETED ·Phase: PHASE3

Investigate Dose of Org 36286 to Initiate Multiple Follicular Growth in a Controlled Ovarian Hyperstimulation Protocol for IVF or IVF/ICSI (P07015)

NCT00702806 ·Status: COMPLETED ·Phase: PHASE2

GnRH Antagonist Pre-treatment for the Prevention of Asynchronous Follicular Growth

NCT05071339 ·Status: UNKNOWN ·Phase: PHASE4

The Results of Preimplantation Genetic Diagnosis and Preimplantation Genetic Screening of Embryos Obtained From GnRH-agonist Long and GnRH-antagonist Ovarian Stimulation Protocol

NCT01636505 ·Status: UNKNOWN ·Phase: PHASE3

Early Follicular Supplementation of Ganirelix in IVF 2004

NCT00461422 ·Status: COMPLETED ·Phase: PHASE4

Premature Luteinization Prevention by GnRH Antagonist in Patients Undergoing IUI

NCT00780858 ·Status: COMPLETED

Cetrorelix and Ganirelix Flexible Protocol for (IVF)

NCT03477929 ·Status: UNKNOWN ·Phase: PHASE4

Luteal Phase Support With Daily Administration of Gonadotropin-releasing Hormone Agonist Compared to Progesterone/Estradiol in IVF/ICSI Cycles With Ovulation Triggering With GnRH-a

NCT05143723 ·Status: UNKNOWN ·Phase: PHASE2

The Letrozole Administration During Luteal Phase

NCT02686151 ·Status: UNKNOWN ·Phase: PHASE3

Luteal Antagonist Versus Conventional Treatment in Women With Severe Early Ovarian Hyperstimulation Syndrome (OHSS)

NCT02392520 ·Status: UNKNOWN ·Phase: NA

Impact of Gonadotrophin Releasing Hormone Analogues on Oocyte and Embryo Quality

NCT03139474 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

The Use of GnRH Agonist Trigger in the Prevention of OHSS

NCT00349258 ·Status: COMPLETED ·Phase: PHASE4

Comparison Between GnRH Agonist and GnRH Antagonist Protocols of Ovarian Stimulation in PCOS Patients

NCT00417144 ·Status: UNKNOWN ·Phase: PHASE4

Evolutive Potential of Embryos Obtained From Oocytes After Luteal Phase Ovarian Stimulation

NCT01645241 ·Status: COMPLETED ·Phase: NA

Single Follicular Dexarelix for LH Suppression During Ovarian Stimulation in Oocyte Donors.

NCT03861715 ·Status: UNKNOWN

Administration of GnRH Antagonist to Oocyte Donation Recipients

NCT00635258 ·Status: COMPLETED

Gonadotropin-releasing Hormone (GnRH) Antagonist During 3 Days

NCT01093443 ·Status: COMPLETED ·Phase: PHASE4

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH

NCT00296465 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Co-administration of Low Dose hCG at the Time of GnRH Agonist Trigger or 35 Hours Later for the Prevention of OHSS

NCT01815138 ·Status: COMPLETED ·Phase: PHASE4

To Compare the Efficacy and Safety of Oral SHR 7280 Tablets With Ganirelix Acetate Injection in Infertile Female Subjects

NCT05994378 ·Status: COMPLETED ·Phase: PHASE3